Starboard's Q2 Moves: New TripAdvisor Position, Salesforce & Pfizer Boosts, Kenvue Trim
ByAinvest
Friday, Aug 15, 2025 1:01 am ET1min read
CRM--
According to the latest 13F filing [2], Starboard increased its position in Salesforce by approximately 50%, owning 1.3 million shares as of June 30, 2025. This move comes after Salesforce's stock price has lost nearly 30% since January and is down nearly 9% over the last 12 months. Despite the recent price decline, Starboard's chief executive, Jeffrey Smith, believes there is still room for the company to become more efficient and profitable [1].
Additionally, Starboard strengthened its position in Pfizer by 10.5%, holding 8.5 million shares as of June 30, 2025. This increase follows a previous $1 billion stake in the company and a push for performance improvements [1].
The hedge fund also took a new position in TripAdvisor, purchasing 8,499,054 shares, and in iShares Russell 2000 ETF, buying 340,000 shares. Meanwhile, Starboard trimmed its stake in Kenvue, reducing its holdings from 22.05 million shares to 20.93 million shares [2].
These strategic moves underscore Starboard's commitment to active management and its belief in the long-term potential of these companies. The hedge fund's actions will be closely monitored by investors and financial professionals for insights into future investment trends.
References:
[1] https://finance.yahoo.com/news/activist-starboard-buys-more-salesforce-230031601.html
[2] https://seekingalpha.com/news/4485801-starboard-takes-new-position-in-tripadvisor-adds-salesforce-and-pfizer-among-q2-moves
PFE--
TRIP--
Starboard, a hedge fund with Bloomberg experience, took a new position in TripAdvisor and iShares Russell 2000 ETF in Q2. The fund also boosted its positions in Salesforce and Pfizer, while trimming its stake in Kenvue. This move demonstrates Starboard's active engagement in the market, diversifying its portfolio with various stocks.
In the second quarter of 2025, hedge fund Starboard Value demonstrated its active engagement in the market by taking new positions in TripAdvisor and iShares Russell 2000 ETF, while also bolstering its stakes in Salesforce and Pfizer. These moves highlight Starboard's strategy to diversify its portfolio and capitalize on potential growth opportunities.According to the latest 13F filing [2], Starboard increased its position in Salesforce by approximately 50%, owning 1.3 million shares as of June 30, 2025. This move comes after Salesforce's stock price has lost nearly 30% since January and is down nearly 9% over the last 12 months. Despite the recent price decline, Starboard's chief executive, Jeffrey Smith, believes there is still room for the company to become more efficient and profitable [1].
Additionally, Starboard strengthened its position in Pfizer by 10.5%, holding 8.5 million shares as of June 30, 2025. This increase follows a previous $1 billion stake in the company and a push for performance improvements [1].
The hedge fund also took a new position in TripAdvisor, purchasing 8,499,054 shares, and in iShares Russell 2000 ETF, buying 340,000 shares. Meanwhile, Starboard trimmed its stake in Kenvue, reducing its holdings from 22.05 million shares to 20.93 million shares [2].
These strategic moves underscore Starboard's commitment to active management and its belief in the long-term potential of these companies. The hedge fund's actions will be closely monitored by investors and financial professionals for insights into future investment trends.
References:
[1] https://finance.yahoo.com/news/activist-starboard-buys-more-salesforce-230031601.html
[2] https://seekingalpha.com/news/4485801-starboard-takes-new-position-in-tripadvisor-adds-salesforce-and-pfizer-among-q2-moves

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet